🇺🇸 FDA
Patent

US 6103709

Therapeutically effective 1.alpha.,25-dihydroxyvitamin D.sub.3 analogs and methods for treatment of vitamin D diseases

expired A61KA61K31/575A61K31/59

Quick answer

US patent 6103709 (Therapeutically effective 1.alpha.,25-dihydroxyvitamin D.sub.3 analogs and methods for treatment of vitamin D diseases) held by The Regents of the University of California expires Mon Aug 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 15 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/575, A61K31/59